← Leaderboards
James K Tsuruta
University Of North Carolina Chapel Hill
$1,284,948
Attributed
$1,284,948
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $229.9K · FY2005–19$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,284,948 · 2
By mechanism
R01$1,132,432 · 1
R03$152,516 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Deborah A O'Brien$7,963,395
- Peter Petrusz$1,501,650
- Frank S French$6,336,781
Others in their field
Top investigators on “Inhibin”
- Martin M Matzuk · University Of Missouri-Columbia$11,443,124
- Russ B Hauser · Harvard University (Sch Of Public Hlth)$10,778,737
- Mary E D'alton · Columbia University Health Sciences$8,517,643
- Marcelle Ivonne Cedars · University Of California San Francisco$6,561,231
- Ellen W Freeman · University Of Pennsylvania$6,078,804
- Janet E Hall · Massachusetts General Hospital$4,703,062
Research focus
InhibinFutureProteinsSignal TransductionCyclin Dependent KinaseDna Binding ProteinFollistatinParacrineActivinsTestisBenignBlood VesselsBody TemperatureBreast Cancer DiagnosisCell ProliferationBlood CirculationContrast MediaAcousticsCarrying CapacitiesCancer TherapyBloodCell Growth RegulationBiotinContraceptives
Grant awards (7)
Increasing sensitivity and discrimination of breast cancer diagnosis using molecularly targeted, extravascular ultrasound imaging with ultrasound-activated, phase-change nanodroplet contrast agent$76,258
R03 · FY2019 · EB · contact PI
Increasing sensitivity and discrimination of breast cancer diagnosis using molecularly targeted, extravascular ultrasound imaging with ultrasound-activated, phase-change nanodroplet contrast agent$76,258
R03 · FY2018 · EB · contact PI
Reversible vitamin A-dependent arrest of spermatogonia$218,035
R01 · FY2007 · HD · contact PI
Reversible vitamin A-dependent arrest of spermatogonia$224,547
R01 · FY2006 · HD · contact PI
Reversible vitamin A-dependent arrest of spermatogonia$229,950
R01 · FY2005 · HD
Reversible vitamin A-dependent arrest of spermatogonia$229,950
R01 · FY2004 · HD
Reversible vitamin A-dependent arrest of spermatogonia$229,950
R01 · FY2003 · HD